Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CARL · against 368 other Healthcare companies of similar size
Ranked #45 of 369 · scores higher than 87% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 80–89, including CARL · Click a bar to see the companies
Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
| Metric | CARL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 383 reported | 65.4% | 2.8% | 92% | 33% | |
| Earnings per share growthHigher is better · 184 reported | Not reported | 3.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 362 reported | Not reported | 3.7% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 43 | 2.4B HKD (≈$310M) | 86 | 52 | |
| 43 | 336M USD | 86 | 43 | |
| 45 | 3.4B CNY (≈$478M) | 85 | 77 | |
| 45 | 2.4B CNY (≈$331M) | 85 | 51 | |
| 45 | 393M USD | 85 | 50 | |
| 45 | 5.1B MXN (≈$274M) | 85 | 48 | |
| 45 | 303M USD | 85 | 27 | |
| 45 | 513M USD | 85 | 31 | |
| 51 | 672.6B KRW (≈$484M) | 84 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score